Adjuvant therapy for pancreatic cancer: a review (Q37020384)

17 August 2017

1 reference

title

Adjuvant therapy for pancreatic cancer: a review (English)

1 reference

17 August 2017

1 reference

Dan S Zuckerman

1

1 reference

PubMed ID

18050292

17 August 2017

David P Ryan

series ordinal

2

1 reference

PubMed ID

18050292

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

112

1 reference

17 August 2017

2

1 reference

17 August 2017

243-249

1 reference

Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation

17 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Impact of hospital volume on operative mortality for major cancer surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Surgeon volume and operative mortality in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Volume-based referral for cancer surgery: informing the debate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Recurrence after resection for ductal adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant radiation therapy for pancreatic cancer: a 15-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Results of surgery and adjuvant radiotherapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Studies of intraoperative radiotherapy in carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Intraoperative radiotherapy for patients with carcinoma of the pancreas. The Howard University Hospital experience, 1978-1986.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre or postoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Preoperative irradiation in carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23174

7 January 2021

Identifiers

DOI

10.1002/CNCR.23174

1 reference

17 August 2017

1 reference

PubMed ID

18050292